SCM
ORIC icon

Sterling Capital Management’s Oric Pharmaceuticals ORIC Stock Holding History

Sterling Capital Management’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.2K Sell
1,126
-575
-34% -$5.21K ﹤0.01% 2115
2026
Q1 		$21.6K Sell
1,701
-1,137
-40% -$12.9K ﹤0.01% 1997
2025
Q4 		$23.2K Sell
2,838
-71
-2% -$817 ﹤0.01% 2145
2025
Q3 		$34.9K Buy
2,909
+2,008
+223% +$21.1K ﹤0.01% 1898
2025
Q2 		$9.14K Buy
901
+67
+8% +$450 ﹤0.01% 2183
2025
Q1 		$4.65K Sell
834
-702
-46% -$6.14K ﹤0.01% 2198
2024
Q4 		$12.4K Buy
1,536
+1,354
+744% +$12.4K ﹤0.01% 2066
2024
Q3 		$1.87K Buy
+182
New +$1.8K ﹤0.01% 2217

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sterling Capital Management's ORIC Position: Q2 2026 in Review

Sterling Capital Management reduced its Oric Pharmaceuticals (ORIC) stake by 34% in Q2 2026, selling an estimated $5.21K and leaving 1,126 shares worth $12.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2115.

Sterling Capital Management first reported a position in ORIC in Q3 2024 and has held it in 8 quarters since. The position peaked at $34.9K in Q3 2025. 181 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Sterling Capital Management held 1,126 shares of Oric Pharmaceuticals worth $12.2K as of Q2 2026.
  • Sterling Capital Management sold 575 Oric Pharmaceuticals shares in Q2 2026, an estimated $5.21K.
  • Oric Pharmaceuticals made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2115 holding.
  • Sterling Capital Management first reported a position in Oric Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Oric Pharmaceuticals position peaked at $34.9K in Q3 2025.
  • 181 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.